Sanders and Cummings Denounce Continued Prescription Drug Price Gouging
WASHINGTON, Oct. 9 – Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) issued the following statement after failing to receive a response from Turing Pharmaceuticals explaining why the company dramatically hiked prices overnight on a lifesaving drug: “Two months ago, former hedge fund manager and Turing CEO Martin Shkreli purchased Daraprim—a drug taken by cancer and AIDS patients—and increased
Citing FDA Nominee’s Ties to Rx Industry, Sanders to Oppose New Commissioner
WASHINGTON, Oct. 9 – With prescription drug prices skyrocketing, Sen. Bernie Sanders (I-Vt.) said today he will vote against confirming Dr. Robert Califf as the new commissioner of the Food and Drug Administration because of his ties to the industry. “At a time when millions of Americans cannot afford to purchase the prescription drugs they need, we need a new
Sanders, Pocan Introduce Legislation to Strengthen Workers’ Rights
WASHINGTON, Oct. 6 – Sen. Bernie Sanders (I-Vt.) and Rep. Mark Pocan (D-Wis.) introduced legislation today that would make it easier for workers to join unions and bargain for better wages, benefits and working conditions. “Millions of Americans who want to join unions are unable to do so because of the coercive and often illegal behavior of their employers,” Sanders
Sanders Statement on Oregon Shootings
BURLINGTON, Vt., Oct. 1 – U.S. Sen. Bernie Sanders (I-Vt.) issued the following statement today after reports that at least 10 people were killed in a shooting at a community college in Roseburg, Oregon: “The American people are horrified by these never-ending mass shootings. Our hearts go out to the families and friends of the innocent victims. As a nation,
Sanders Condemns Price Gouging by Drug Companies
WASHINGTON, Sept. 29 – Comparing drug prices in the United States to those in other countries, Sen. Bernie Sanders (I-Vt.) today condemned pharmaceutical companies that charge American consumers the highest prices in the world for prescription drugs. “It is unacceptable that the top three pharmaceutical companies made a combined $45 billion in profits last year and spent more on sales